Potentiation of adrenergic cardiovascular effects of two quaternary nicotine analogues by reserpine.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D002463:Cell Membrane Permeability / Q000187:drug effects; D003891:Desipramine / Q000494:pharmacology; D004336:Drug Antagonism; D004357:Drug Synergism; D006339:Heart Rate / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008995:Monoamine Oxidase / Q000502:physiology; D008996:Monoamine Oxidase Inhibitors; D009538:Nicotine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011299:Prenylamine / Q000494:pharmacology; D011726:Pyridinium Compounds / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology*
D006584:Hexamethonium Compounds; D008996:Monoamine Oxidase Inhibitors; D011726:Pyridinium Compounds; D009538:Nicotine; D012110:Reserpine; D008995:Monoamine Oxidase; D011299:Prenylamine; D003891:Desipramine